Skip to main content

infliximab

 

Status: AWMSG assessment in progress

For the off-label treatment of Immune Checkpoint Inhibitor (ICI) induced grade 3-4 myocarditis that has not responded to first line immunosuppression with corticosteroids.

Medicine details

Medicine name infliximab
Formulation powder for solution for infusion
Reference number OW31
Indication

As above

Company various
BNF chapter Malignant disease & immunosuppression
Submission type One Wales
Status AWMSG assessment in progress
Scrutiny Panel meeting date 06/03/2025
OWMAG meeting date TBC
AWMSG meeting date TBC
Date of issue TBC
Follow AWTTC: